Skip to main content
. 2020 Jul 10;26(4):492–505. doi: 10.3350/cmh.2020.0005

Figure 3.

Figure 3.

Overall survival rate in regards to the serum levels of (A) myostatin, (B) follistatin, and (C) serum IL-6. In Kaplan-Meier survival analysis, the overall 5-year survival rate was not different between the high (74.8%) and low myostatin (68.0%) group (P=0.062) (A). However, the high follistatin group had a significantly shorter 5-year overall survival rate (78.4%) than that of the low follistatin group (89.6%, P<0.001) (B). Likewise, the high IL-6 group had a significantly shorter 5-year overall survival rate (78.4%) than that of the low IL-6 group (85.8%, P=0.018) (C). IL-6, interleukin-6.